Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0PLFZB
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
M02-SG3249
|
|||||
| Synonyms |
M02-SG3249
Click to Show/Hide
|
|||||
| Organization |
MEDIMMUNE, LLC
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1.84
|
|||||
| Structure |
|
|||||
| Antibody Name |
M02
|
Antibody Info | ||||
| Antigen Name |
Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)
|
Antigen Info | ||||
| Payload Name |
SG3199
|
Payload Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
CL2A
|
Linker Info | ||||
| Conjugate Type |
Cysteine-maleimide conjugation
|
|||||
| Combination Type |
SG3249
|
|||||